Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans

American Journal of Kidney Diseases

Volumn 33, Issue 3, 1999, Pages

  Faich, G ^a   Strobos, J ^a   Matzke, G R ^a  

^a PC   (United States)

Author keywords

Iron dextran; Iron deficiency anemia; Renal hemodialysis; Sodium ferric gluconate complex in sucrose

Indexed keywords

FERRIC GLUCONATE; IRON DEXTRAN; IRON LECITHIN COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC KIDNEY FAILURE; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; IRON THERAPY;

EID: 0033012811     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-6386(99)70183-6     Document Type: Article

References (17)

1. RM Lindsay JA Burton N Edward HJ Dargie CRM Prentice AC Kennedy Dialyzer blood loss Clin Nephrol 1 1973 29 34
2. RE Longnecker JA Goffinet ED Hendler Blood loss during maintenance hemodialysis Trans Am Soc Artif Internal Organs 20 1974 135 141
3. G Sunder-Plassman WL Hörl Erythropoietin and iron Clin Nephrol 47 1997 141 157
4. DE Muller-Wiefel H Sinn G Gilli K Scharer Hemolysis and blood loss in children with chronic renal failure Clin Nephrol 8 1977 481 486
5. WH Hörl K Dreyling HB Steinhauer R Engelhardt P Schollmeyer Iron status of dialysis patients under rHuEPO therapy Contrib Nephrol 87 1990 78 86
6. S Fishbane GL Frei J Maesaka Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation Am J Kidney Dis 26 1995 41 46
7. IC Macdougall B Tucker J Thompson CRV Tomson LRI Baker AEG Raine A randomized controlled study of iron supplementation in patients treated with erythropoietin Kidney Int 50 1996 1694 1699
8. National Kidney Foundation Study Group: NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure Am J Kidney Dis 30 suppl 3 1997 S192 S237
9. RD Hamstra MH Block AL Schocket Intravenous iron dextran in clinical medicine JAMA 243 1980 1726 1731
10. J Woodman RJ Shaw AJ Shipman AM Edwards A surveillance programme on Imferon Pharmaceut Med 1 1987 289 296
11. S Fishbane V-D Ungureanu JK Maesaka CJ Kaupke V Lim J Wish The safety of intravenous iron dextran in hemodialysis patients Am J Kidney Dis 28 1996 529 534
12. J Pascual JL Terual F Liano A Sureda J Ortuna Serious adverse reactions after intravenous ferric gluconate Nephrol Dial Transplant 7 1992 271 272
13. AL Zanen HJ Adriaansen EFH van Brommel R Posthuma GMTh de Jong Oversaturation of transferrin after intravenous ferric gluconate (Ferrlecit) in hemodialysis patients Nephrol Dial Transplant 11 1996 820 824
14. HM Mudge IM Weiner Agents affecting volume and composition of body fluids ed 8 AG Gilman TW Rall AS Nies P Taylor Goodman and Gilman's The Pharmacological Basis of Therapeutics 1990 Pergamon Press New York, NY 682 707
15. GA Faich Adverse drug reaction surveillance N Engl J Med 314 1986 1589 1592
16. GA Faich US adverse drug reaction surveillance 1989-94 Pharmacoepidemiol Drug Saf 5 1997 393 398
17. AW Richter K Granath G Östling Anaphylactic reactions in connection with infusion of invert sugar solutions are due to macromolecular contaminants Int Arch Allergy Immunol 50 1976 606 612